LabCompass

Simon Warren

Medicine · Indiana University

OpenAlex ORCID
Orthopedic Infections and TreatmentsCutaneous Melanoma Detection and ManagementSurgical site infection preventionMelanoma and MAPK PathwaysCutaneous lymphoproliferative disorders research

Publications

103

Citations

2,574

Est. group size

~2

Recurring co-author estimate

Active years

60

Publishing since 1967

Research summary
AI-generated

Simon Warren conducts clinical medical research focused on infections related to orthopaedic surgery, particularly those affecting joint replacements and bone tumour implants (endoprostheses). A related strand of work involves the microscopic and molecular diagnosis of skin and lymph-node tumours, especially melanoma and related melanocytic growths. The research emphasizes practical questions such as how best to use antibiotics to prevent and treat infection.

Orthopaedic implant and joint infectionsAntibiotic prophylaxis and antimicrobial treatmentMelanoma and melanocytic tumour pathologyDiagnostic microbiology (e.g. mycobacteria, resistant bacteria)COVID-19 in healthcare worker cohorts

Publication activity has been variable over the last decade, dipping around 2021-2022 before rebounding, with a recent output of roughly five papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.8/year recently
2017: 5 publications172018: 13 publications13182019: 6 publications192020: 7 publications202021: 3 publications212022: 1 publication222023: 11 publications232024: 6 publications242025: 6 publications2526
Recent publications
Publishes in
  • Journal of Bone and Joint Infection×6
  • Journal of Cutaneous Pathology×5
  • Orthopaedic Proceedings×5
  • JAAD Case Reports×3
  • Journal of Antimicrobial Chemotherapy×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile